About this opportunity:
At Freenome, we are seeking a Research Associate II to help grow the Freenome Genomics Late Stage Development team. The ideal candidate is highly analytical and detail-oriented, with a strong foundation in molecular biology and knowledge of next-generation sequencing (NGS) technologies. This person is responsible for all things related to developing and validating clinical-grade assays to measure complex, blood-based analytes (e.g., whole-genome sequencing of cfDNA). You are passionate about advancing cancer diagnostics, and you will have a significant impact on the continued growth of an organization dedicated to changing the entire landscape of cancer.
The role reports to the Manager of Genomics Late Stage Development. This role will be an onsite role based in our Brisbane, California headquarters.
What you’ll do:
Must haves:
Nice to haves:
Benefits and additional information:
The US target range of our hourly rate for new hires is $31.67 - $49.52. You will also be eligible to receive pre-IPO equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ freenome.com/job-openings/ for additional company information.
Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
Applicants have rights under Federal Employment Laws.
#LI-ONSITE